Roche Holding AG
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a RHHBF research report →
About the company
Founded in 1896 and headquartered in Basel, Switzerland, Roche Holding AG is a global enterprise active in both the pharmaceutical and diagnostics sectors. Its extensive operations cover numerous countries, including Switzerland, Germany, the United States, Austria, the Netherlands, the United Kingdom, France, and Belgium, alongside other international markets. The company's pharmaceutical division develops and provides therapies addressing a broad spectrum of medical conditions.
- CEO
- Thomas Schinecker
- IPO
- 2012
- Employees
- 103,249
- HQ
- Basel, CH
Price Chart
- Market Cap
- $344.67B
- P/E
- 21.05
- P/S
- 4.41
- P/B
- 8.02
- EV/EBITDA
- 13.18
- Div Yield
- 2.88%
- Gross Margin
- 73.53%
- Op Margin
- 31.32%
- Net Margin
- 20.94%
- ROE
- 41.23%
- ROIC
- 20.28%
- Revenue
- $61.55B · -1.36%
- Net Income
- $12.89B · 55.69%
- EPS
- $16.19 · 55.82%
- Op Income
- $16.37B
- FCF YoY
- -6.60%
- 52W High
- $514.08
- 52W Low
- $296.10
- 50D MA
- $419.36
- 200D MA
- $411.58
- Beta
- 0.34
- Avg Volume
- 101
Get TickerSpark's AI analysis on RHHBF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our RHHBF coverage
Recent articles, reports, and earnings notes.
No research on RHHBF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate RHHBF report →Similar companies
Peers in the same neighborhood.